Regulation of Inflammatory Genes in Psoriasis

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 19, 2017

Keywords

ClinConnect Summary

This clinical trial is looking at how certain genes involved in inflammation affect psoriasis, a long-lasting skin condition that causes red, scaly patches. The researchers want to better understand the immune system's role in psoriasis to help manage and treat the condition more effectively.

To participate in this trial, you need to be at least 19 years old and have a clinical diagnosis of psoriasis. The study is open to all genders and various skin types. If you join, you may undergo tests to measure how your skin reacts and how your body’s immune system is involved in your psoriasis. However, there are some criteria that may exclude you from the study, such as having certain allergies or being pregnant. If you're interested and meet the requirements, this trial could be an important opportunity to contribute to psoriasis research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of psoriasis
• • Must be age 19 or older.
• • Must be Fitzpatrick skin type I, II, III, IV, V, VI.
• Exclusion Criteria:
• • Subjects who do not have photosensitive disease and are not on photosensitizing medications.
• • Subjects with a history of keloids (who are more likely to develop hypertrophic scars following skin biopsy).
• • Subjects who have an allergy to local anesthetics, antibiotics and/or anticoagulants.
• • Subjects who are pregnant.